These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31698190)

  • 21. Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene.
    Baskfield A; Li R; Beers J; Zou J; Liu C; Zheng W
    Stem Cell Res; 2019 May; 37():101436. PubMed ID: 31009819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency.
    Sacharow SJ; Dudenhausen EE; Lomelino CL; Rodan L; El Achkar CM; Olson HE; Genetti CA; Agrawal PB; McKenna R; Kilberg MS
    Mol Genet Metab; 2018 Mar; 123(3):317-325. PubMed ID: 29279279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first report of Japanese patients with asparagine synthetase deficiency.
    Yamamoto T; Endo W; Ohnishi H; Kubota K; Kawamoto N; Inui T; Imamura A; Takanashi JI; Shiina M; Saitsu H; Ogata K; Matsumoto N; Haginoya K; Fukao T
    Brain Dev; 2017 Mar; 39(3):236-242. PubMed ID: 27743885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
    Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
    Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketogenic diet-responsive drug-resistant epilepsy in a case of asparagine synthetase deficiency with a novel compound heterozygous missense variant.
    Altıntaş M; Yıldırım M; Uçar Çİ; Köse E; Bektaş Ö; Teber S
    Clin Neurol Neurosurg; 2023 Jul; 230():107772. PubMed ID: 37167844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
    Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
    Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperekplexia, microcephaly and simplified gyral pattern caused by novel ASNS mutations, case report.
    Seidahmed MZ; Salih MA; Abdulbasit OB; Samadi A; Al Hussien K; Miqdad AM; Biary MS; Alazami AM; Alorainy IA; Kabiraj MM; Shaheen R; Alkuraya FS
    BMC Neurol; 2016 Jul; 16():105. PubMed ID: 27422383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene.
    Masneri S; Ferraro RM; Lanzi G; Piovani G; Mori L; Barisani C; Moratto D; Plebani A; Badolato R; Soresina A; Giliani S
    Stem Cell Res; 2019 Dec; 41():101596. PubMed ID: 31669783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The first report of a Korean/Vietnamese child with novel pathogenic variants in Asparagine Synthetase Deficiency (ASNSD) with evolving epilepsy syndromes.
    Lee SJ; Na JH; Lee H; Lee YM
    Seizure; 2024 Jan; 114():53-56. PubMed ID: 38043418
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical, molecular, and biochemical delineation of asparagine synthetase deficiency in Saudi cohort.
    Alharby E; Faqeih EA; Saleh M; Alameer S; Almuntashri M; Pastore A; Samman MA; Alnawfal AM; Hashem M; Zaytuni D; Alharbi G; Almannai M; Alasmari A; Mahmoud AA; Alwadei AH; Jad L; AlOtaibi A; Al-Hakami F; Eyaid W; Alkuraya FS; Alfadhel M; Peake RWA; Almontashiri NAM
    Genet Med; 2020 Dec; 22(12):2071-2080. PubMed ID: 32741967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of induced pluripotent stem cell line (IPTi001-A) from a 62-year old sporadic Alzheimer's disease patient with APOE3 (ε3/ε3) genotype.
    Zhang L; Xu M; Liu G; Wu R; Meng S; Xiahou K; Jiang N; Zhang Y; Zhou W
    Stem Cell Res; 2019 Dec; 41():101589. PubMed ID: 31689594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing.
    Hosseini Far H; Patria YN; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
    Stem Cell Res; 2019 May; 37():101449. PubMed ID: 31075690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene.
    Huang W; Xu M; Li R; Baskfield A; Kouznetsova J; Beers J; Zou J; Liu C; Zheng W
    Stem Cell Res; 2019 May; 37():101427. PubMed ID: 30933722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation.
    Schwarz N; Uysal B; Rosa F; Löffler H; Mau-Holzmann UA; Liebau S; Lerche H
    Stem Cell Res; 2019 May; 37():101445. PubMed ID: 31075689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3.
    Soong BW; Syu SH; Wen CH; Ko HW; Wu ML; Hsieh PC; Hwang SM; Lu HE
    Stem Cell Res; 2017 Jan; 18():29-32. PubMed ID: 28395798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.
    Lamolda M; Montes R; Simón I; Perales S; Martínez-Navajas G; Lopez-Onieva L; Ríos-Pelegrina R; Del Moral RG; Griñan-Lison C; Marchal JA; Lozano ML; Ramos-Mejia V; Rivera J; Bastida JM; Real PJ
    Stem Cell Res; 2019 Dec; 41():101603. PubMed ID: 31698193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene.
    Cheng YS; Li R; Baskfield A; Beers J; Zou J; Liu C; Zheng W
    Stem Cell Res; 2019 May; 37():101435. PubMed ID: 31026687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of AlphaMissense predictions in Asparagine Synthetase deficiency variant classification.
    Staklinski SJ; Scheben A; Siepel A; Kilberg MS
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
    Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
    Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.